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Title: UK qualitative focus group study investigating current provision of care for people with 
Microscopic colitis  
Introduction: Microscopic colitis (MC) is a common cause of chronic, non-bloody watery 
diarrhoea that impacts health-related quality of life. No UK guidelines currently exist for MC. 
This has a potential negative sequalae to patients as misdiagnoses and use of inappropriate 
treatments have been reported. This study examines UK provision of care for MC patients, 
with the ambition of developing a consensus document to support health care professionals 
in the future.  
Methods: This qualitative study involved four focus groups, and was conducted between 
March and December 2018. It involved a total of 27 expert participants (IBD-specialist 
nurses (n=8), gastroenterologists (n=7), general practitioners (n=5), colorectal surgeons 
(n=2), pharmacists (n=2), a histopathologist (n=1) and clinical commissioners (n=2). All 
participants were given pre-sessional information. Facilitated discussion was then 
undertaken between experts on key topic areas, and culminated in key themes being 
identified, which were then further analysed. 
Results: The following themes were identified to influence patient care and outcomes: 1) 
Awareness. A lack of awareness particularly in primary care, and perceptions that MC is less 
common than conventional inflammatory bowel diseases were felt to be factors influencing 
diagnosis and management. 2) Symptom overlap with IBS.  As symptomatology for both MC 
and IBS are similar, the expert group felt referrals to secondary care are likely to be 
restricted, leading to increased GP visits, enhanced use of over the counter medications, 
and diminished quality of life. 3) Faecal calprotectin (FC). The expert group felt referral 
practice from primary care was too reliant on FC as a discriminator, as active MC can have 
FC levels below the conventional referral thresholds. 4) Biopsies. The expert group identified 
that the diagnosis of MC may be missed as endoscopists neglect to take colonic biopsies, 
either through a lack of awareness, or determined by time and cost restrictions. 5) 
Treatment. This theme demonstrated significant variations in clinical practice, with an array 
of  therapeutic interventions used to manage MC. Clinicians frequently lacked awareness of 
MC treatments and were not aware that budesonide is the only established treatment, as 
evidenced in randomised-controlled trials. 
Conclusions: This is the first study to examine service provision for MC in the UK. Key 
themes have been identified through expert opinion, demonstrating why optimal diagnosis 
and management of MC has been difficult to operationalise in the UK.  These findings will be 
used to develop a consensus document that has benefits to healthcare professionals and 
patients.   
 
